Clinician-trialist rounds: 16. Mind your explanatory and pragmatic attitudes! – part 1: what?

Perera GA . Antihypertensive drug versus symptomatic treatment in primary hypertension: Effect on survival. JAMA 1960; 173: 95–97.

Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension: Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. JAMA 1967; 202: 116–22.

Sackett DL . The hypertensive patient: 2. Finding and linking to clinical care. Can Med Assoc J 1979; 120: 1477–78.

Sackett DL . The hypertensive patient: 5. Compliance with therapy. Can Med Assoc J 1979; 121: 259–61.

Kaczorowski J Chambers LW Dolovich L . Improving cardiovascular health at population level: 39 community cluster randomized trial of Cardiovascular Health Awareness Program (CHAP). BMJ 2011; 342: d442.

Schwartz D Lellouch J . Explanatory and pragmatic attitudes in therapeutical trials. J Chronic Dis 1967; 20: 637–48.

Goeree R von Keyserlingk C Burke N . Economic appraisal of a community-wide cardiovascular health awareness program. Value Health 2013; 16: 39–45.

Schwartz D Flamant R Lellouch J . Clinical Trials. Academic Press, London, 1980.

Cochrane A . Effectiveness and Efficiency: Random Reflections on Health Services. Nuffield Provincial Hospitals Trust, London, 1972.

Sackett DL Gent M . Controversy in counting and attributing events in clinical trials. N Engl J Med 1979; 301: 1410–12.